Pallàs, M.; Vázquez, S.; Sanfeliu, C.; Galdeano, C.; Griñán-Ferré, C.
Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy. Biomolecules 2020, 10, 703.
https://doi.org/10.3390/biom10050703
AMA Style
Pallàs M, Vázquez S, Sanfeliu C, Galdeano C, Griñán-Ferré C.
Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy. Biomolecules. 2020; 10(5):703.
https://doi.org/10.3390/biom10050703
Chicago/Turabian Style
Pallàs, Mercè, Santiago Vázquez, Coral Sanfeliu, Carles Galdeano, and Christian Griñán-Ferré.
2020. "Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy" Biomolecules 10, no. 5: 703.
https://doi.org/10.3390/biom10050703
APA Style
Pallàs, M., Vázquez, S., Sanfeliu, C., Galdeano, C., & Griñán-Ferré, C.
(2020). Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy. Biomolecules, 10(5), 703.
https://doi.org/10.3390/biom10050703